SRI-31142 is a putative brain-penetrant allosteric inhibitor of the dopamine transporter (DAT); it reduces intracranial self-stimulation (ICSS) responding and nucleus accumbens (NAc) dopamine levels at effective doses without producing abuse-related effects typical of cocaine and GBR-12935; it also blocks cocaine-induced increases in ICSS and NAc dopamine.